OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Recommendations for the Equitable and Widespread Implementation of Liquid Biopsy for Cancer Care
Phillip G. Febbo, Mina Alsaraf Allo, Emma B. Alme, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 25
Phillip G. Febbo, Mina Alsaraf Allo, Emma B. Alme, et al.
JCO Precision Oncology (2024), Iss. 8
Open Access | Times Cited: 25
Showing 25 citing articles:
A scoping review of factors influencing the implementation of liquid biopsy for cancer care
S. Sheriff, Maree Saba, R Patel, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
S. Sheriff, Maree Saba, R Patel, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access | Times Cited: 1
An Interdisciplinary Perspective on Improving Cancer Care in the State of Mississippi as an Example of Cancer Care Improvements in the Global South
Mae Jones, Srinivasan Vijayakumar, Mary R Nittala, et al.
Cureus (2025)
Open Access
Mae Jones, Srinivasan Vijayakumar, Mary R Nittala, et al.
Cureus (2025)
Open Access
Liquid biopsy: an emerging field with new opportunities for cancer diagnosis and prognosis
Dhahiri Saidi Mashausi, Herve Semukunzi
Asia-Pacific Journal of Oncology (2025), pp. 9-17
Open Access
Dhahiri Saidi Mashausi, Herve Semukunzi
Asia-Pacific Journal of Oncology (2025), pp. 9-17
Open Access
Analytical Validation of the Labcorp Plasma Complete Test, a Cell-free DNA Comprehensive Genomic Profiling Tool for Precision Oncology
Ellen L. Verner, Jennifer Jackson, Cynthia Maddox, et al.
Journal of Molecular Diagnostics (2025)
Open Access
Ellen L. Verner, Jennifer Jackson, Cynthia Maddox, et al.
Journal of Molecular Diagnostics (2025)
Open Access
Clinical Validation of Local Versus Commercial Genomic Testing in Cancer: A Comparison of Tissue and Plasma Concordance
Lucy G. Faulkner, Lynne M. Howells, Susann Lehmann, et al.
Cancer Investigation (2025), pp. 1-22
Open Access
Lucy G. Faulkner, Lynne M. Howells, Susann Lehmann, et al.
Cancer Investigation (2025), pp. 1-22
Open Access
Plasma ctDNA kinetics as a predictor of systemic therapy response for advanced non-small cell lung cancer: a systematic review and meta-analysis
Luis Felipe Leite da Silva, Erick Figueiredo Saldanha, J. Menezes, et al.
The Oncologist (2025) Vol. 30, Iss. 2
Open Access
Luis Felipe Leite da Silva, Erick Figueiredo Saldanha, J. Menezes, et al.
The Oncologist (2025) Vol. 30, Iss. 2
Open Access
Implementation of Cancer Genomics in the United States: Views of Payers and Other Stakeholders on Challenges and the Role of Payers in Solutions
Julia R. Trosman, Christine B. Weldon, Allison W. Kurian, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Julia R. Trosman, Christine B. Weldon, Allison W. Kurian, et al.
JCO Precision Oncology (2025), Iss. 9
Closed Access
Establishing a Common Lexicon for Circulating Tumor DNA Analysis and Molecular Residual Disease: Insights From the BLOODPAC Consortium
Andrew G. Hadd, Angela Silvestro, Brittany McKelvey, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 3
Open Access
Andrew G. Hadd, Angela Silvestro, Brittany McKelvey, et al.
Clinical and Translational Science (2025) Vol. 18, Iss. 3
Open Access
Why we need molecular testing guidelines for lung cancer in Australia
Vivek Rathi
Pathology (2025)
Closed Access
Vivek Rathi
Pathology (2025)
Closed Access
Multicancer early detection testing: Guidance for primary care discussions with patients
Richard M. Hoffman, Andrew M. D. Wolf, Sana Raoof, et al.
Cancer (2025) Vol. 131, Iss. 7
Open Access
Richard M. Hoffman, Andrew M. D. Wolf, Sana Raoof, et al.
Cancer (2025) Vol. 131, Iss. 7
Open Access
Circulating Tumor DNA as a Complementary Prognostic Biomarker during CAR-T Therapy in B-Cell Non-Hodgkin Lymphomas
Sarah Monick, Allison Rosenthal
Cancers (2024) Vol. 16, Iss. 10, pp. 1881-1881
Open Access | Times Cited: 4
Sarah Monick, Allison Rosenthal
Cancers (2024) Vol. 16, Iss. 10, pp. 1881-1881
Open Access | Times Cited: 4
Translation of Epigenetics in Cell-Free DNA Liquid Biopsy Technology and Precision Oncology
Wan Ying Tan, Snigdha Nagabhyrava, Olivia Ang-Olson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6533-6565
Open Access | Times Cited: 4
Wan Ying Tan, Snigdha Nagabhyrava, Olivia Ang-Olson, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 7, pp. 6533-6565
Open Access | Times Cited: 4
Point of Care Liquid Biopsy for Cancer Treatment—Early Experience from a Community Center
C. J. Nicholas, Andrea Beharry, Anna Bendzsak, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2505-2505
Open Access | Times Cited: 3
C. J. Nicholas, Andrea Beharry, Anna Bendzsak, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2505-2505
Open Access | Times Cited: 3
Optimizing Access to Liquid Biopsy in the Present and Future Cancer Landscape
Arielle J. Medford, Leif W. Ellisen
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
Arielle J. Medford, Leif W. Ellisen
JCO Precision Oncology (2024), Iss. 8
Closed Access | Times Cited: 2
Status of breast cancer detection in young women and potential of liquid biopsy
Maya Stibbards-Lyle, Julia Malinovska, Seleem Badawy, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Maya Stibbards-Lyle, Julia Malinovska, Seleem Badawy, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Clinical validation of a tissue-agnostic genome-wide methylome enrichment MRD assay for head and neck malignancies
Geoffrey Liu, Shao Hui Huang, Laurie Ailles, et al.
Annals of Oncology (2024)
Open Access | Times Cited: 2
Geoffrey Liu, Shao Hui Huang, Laurie Ailles, et al.
Annals of Oncology (2024)
Open Access | Times Cited: 2
Blood-Based Multi-Cancer Early Detection Tests (MCEDs) as a Potential Approach to Address Current Gaps in Cancer Screening
Chantelle Carbonell, J. Hutchinson, Robert J. Hilsden, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
Chantelle Carbonell, J. Hutchinson, Robert J. Hilsden, et al.
Cancer Control (2024) Vol. 31
Open Access | Times Cited: 2
The Role of Liquid Biopsy as a Catalyst for Sustained Progress in Precision Oncology – Perspective of The Young Committee of The International Society of Liquid Biopsy
Erick Figueiredo Saldanha, Eleonora Nicolò, Konstantinos Venetis, et al.
The Journal of Liquid Biopsy (2024) Vol. 5, pp. 100156-100156
Closed Access | Times Cited: 1
Erick Figueiredo Saldanha, Eleonora Nicolò, Konstantinos Venetis, et al.
The Journal of Liquid Biopsy (2024) Vol. 5, pp. 100156-100156
Closed Access | Times Cited: 1
The Role of ctDNA and Liquid Biopsy in the Diagnosis and Monitoring of Head and Neck Cancer: Towards Precision Medicine
Sami I. Nassar, Amber Suk, Shaun A. Nguyen, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3129-3129
Open Access | Times Cited: 1
Sami I. Nassar, Amber Suk, Shaun A. Nguyen, et al.
Cancers (2024) Vol. 16, Iss. 18, pp. 3129-3129
Open Access | Times Cited: 1
Deficits of Molecular Prognosis/Diagnosis Studies in Underserved Populations
Arielle J. Medford, Beverly Moy
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1515-1522
Closed Access | Times Cited: 1
Arielle J. Medford, Beverly Moy
JCO Oncology Practice (2024) Vol. 20, Iss. 11, pp. 1515-1522
Closed Access | Times Cited: 1
Exploring the clinical utility of liquid biopsy with cfDNA in cancer: A systematic review
Keerthi Ranganathan, Neethu Sheri Kurian, Hitesh M. Goswami, et al.
The Journal of Liquid Biopsy (2024) Vol. 5, pp. 100150-100150
Closed Access
Keerthi Ranganathan, Neethu Sheri Kurian, Hitesh M. Goswami, et al.
The Journal of Liquid Biopsy (2024) Vol. 5, pp. 100150-100150
Closed Access
EBCC-14 manifesto: Addressing disparities in access to innovation for patients with metastatic breast cancer across Europe
Michail Ignatiadis, Fiorita Poulakaki, Tanja Spanic, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114156-114156
Closed Access
Michail Ignatiadis, Fiorita Poulakaki, Tanja Spanic, et al.
European Journal of Cancer (2024) Vol. 207, pp. 114156-114156
Closed Access
Targeted therapies in advanced biliary malignancies: a clinical review
Udhayvir Singh Grewal, Shiva Jashwanth Gaddam, Muhammad Shaalan Beg, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 9, pp. 869-880
Closed Access
Udhayvir Singh Grewal, Shiva Jashwanth Gaddam, Muhammad Shaalan Beg, et al.
Expert Review of Anticancer Therapy (2024) Vol. 24, Iss. 9, pp. 869-880
Closed Access
A Promising Step Forward With Giant Leaps Ahead
Narek Shaverdian, Bob T. Li, James M. Isbell, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 10, pp. 1370-1372
Closed Access
Narek Shaverdian, Bob T. Li, James M. Isbell, et al.
Journal of Thoracic Oncology (2024) Vol. 19, Iss. 10, pp. 1370-1372
Closed Access
The global progress and quality assessment of research on the association between circulating tumor DNA and clinical prognosis: a systematic review
Meng Zhang, Xiaowei Chen, Qingxin Zhou, et al.
Journal of the National Cancer Center (2024)
Open Access
Meng Zhang, Xiaowei Chen, Qingxin Zhou, et al.
Journal of the National Cancer Center (2024)
Open Access
